CGON
NASDAQStockCG Oncology, Inc. Common stock
$62.03-2.63 (-4.07%)
52-Week Range
$15.59
$64.66
Key Stats
Market Cap
5.2B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.19
Volume
1.5M
Avg Volume
1.2M
Performance
1M
+21.79%
3M
+57.94%
6M
+86.88%
YTD
+54.73%
1Y
+142.90%
3Y
+73.96%
5Y
+73.96%
Price Chart
ETF Exposure
CGON is held by 83 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SBIO | ALPS Medical Breakthroughs ETF | 3.25% |
| CANC | Tema Oncology ETF | 2.08% |
| XBI | State Street SPDR S&P Biotech ETF | 1.40% |
| BBC | Virtus Biotech Clinical Trials ETF | 1.14% |
| AGNG | Global X - Aging Population ETF | 0.84% |
| JDOC | JPMorgan Healthcare Leaders ETF | 0.77% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.76% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 0.76% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.49% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.45% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.39% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.37% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.28% |
| IWO | iShares Russell 2000 Growth ETF | 0.28% |
| IBB | iShares Biotechnology ETF | 0.27% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.26% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.25% |
| PWS | Pacer WealthShield ETF | 0.24% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.20% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.20% |
| STXK | Strive Small-Cap ETF | 0.19% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.18% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.17% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.15% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.15% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.14% |
| FPX | First Trust US Equity Opportunities ETF | 0.13% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.12% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.12% |
| IWM | iShares Russell 2000 ETF | 0.12% |
| RSSL | Global X - Russell 2000 ETF | 0.11% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.10% |
| VTWO | Vanguard Russell 2000 ETF | 0.09% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.09% |
| VBR | Vanguard Small-Cap Value ETF | 0.08% |
| UWM | ProShares - Ultra Russell2000 | 0.08% |
| URTY | ProShares - UltraPro Russell2000 | 0.07% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.07% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.06% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.06% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.06% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.05% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.05% |
| VB | Vanguard Small-Cap ETF | 0.05% |
| VXF | Vanguard Extended Market ETF | 0.04% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.04% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.04% |
| VHT | Vanguard Health Care ETF | 0.03% |
| SMMD | iShares Russell 2500 ETF | 0.03% |
| WSML | iShares MSCI World Small-Cap ETF | 0.03% |
Page 1 of 2Next
About CGON ETF Exposure
CG Oncology, Inc. Common stock (CGON) is held by 83 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 5.2B, CGON is a widely held institutional stock. The stock currently trades at $62.03. Investors can gain exposure to CGON through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CGON, sorted by portfolio weight.